Episurf Medical AB (OSTO:EPIS B) FCF Margin %: 340.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Episurf Medical AB FCF Margin %?

Episurf Medical AB OSTO:EPIS B +1.27% FCF Margin % is 340.00% as of Mar. 2026. The stock has 7 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Episurf Medical AB ranks worse than 89.94% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Episurf Medical AB's Free Cash Flow for the three months ended in Mar. 2026 was kr10.20 Mil. Episurf Medical AB's Revenue for the three months ended in Mar. 2026 was kr3.00 Mil. Therefore, Episurf Medical AB's FCF Margin % for the quarter that ended in Mar. 2026 was 340.00%.

As of today, Episurf Medical AB's current FCF Yield % is -8.87%.

The historical rank and industry rank for Episurf Medical AB's FCF Margin % or its related term are showing as below:

OSTO:EPIS B' s FCF Margin % Range Over the Past 10 Years
Min: -2752   Med: -1199.12   Max: -273.02
Current: -273.02

During the past 13 years, the highest FCF Margin % of Episurf Medical AB was -273.02%. The lowest was -2752.00%. And the median was -1199.12%.

OSTO:EPIS B's FCF Margin % is ranked worse than
89.94% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -0.56 vs OSTO:EPIS B: -273.02

Episurf Medical AB FCF Margin % Related Terms

Episurf Medical AB FCF Margin % Historical Data

* Premium members only.

The historical data trend for Episurf Medical AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Episurf Medical AB FCF Margin % Chart

Episurf Medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,026.15 -1,224.24 -915.53 -607.69 -459.26

Episurf Medical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -558.62 -484.38 -368.57 340.00

OSTO:EPIS B vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, Episurf Medical AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Episurf Medical AB FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Episurf Medical AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Episurf Medical AB's FCF Margin % falls into.


Episurf Medical AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Episurf Medical AB's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-62/13.5
=-459.26 %

Episurf Medical AB's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=10.2/3
=340.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 340.00% mean?
Episurf Medical AB (OSTO:EPIS B) has a FCF Margin % of 340.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Episurf Medical AB and its competitors. According to the industry distribution chart, Episurf Medical AB ranks #733 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 89.9%.
Is Episurf Medical AB's FCF Margin % too high?
Episurf Medical AB's current FCF Margin % is 340.00%. Based on the distribution chart, Episurf Medical AB ranks #733 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Episurf Medical AB's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Episurf Medical AB ranks #733 out of 815 companies for FCF Margin %. This places Episurf Medical AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Episurf Medical AB and its competitors. Episurf Medical AB's current FCF Margin % is 340.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Episurf Medical AB stock overvalued right now?
Based on GuruFocus' analysis, Episurf Medical AB (OSTO:EPIS B) is currently considered Modestly Overvalued. The stock's GF Value™ is kr0.05, compared to a current price of kr0.06 — trading 11.8% above its estimated fair value. The current FCF Margin % is 340.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Episurf Medical AB (OSTO:EPIS B), the current FCF Margin % is 340.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Episurf Medical AB Business Description

Other Exchanges 0QUT:UK16E:Germany
Address Karlavagen 60, Stockholm, SWE, 114 49
Episurf Medical AB is a medical device company. The company develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints. Its first patient-specific product portfolio, the knee portfolio, consists of the existing products Episealer Condyle Solo and Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, and Epioscopy. Episealer Patellofemoral System for the treatment of osteoarthritis limited to thepatellofemoral part of the knee joint. The company is forming a new strategic business segment through the acquisition of real estate assets.